TNDM Tandem posts far narrower Q4 2025 loss than estimates yet shares dip slightly in daily trading AvalonBay Communities AVB Q1 2026 Earnings Beat Signals Valuation Opportunity as Share Price Rebounds The recurring revenue story behind Jyong Biotech MENS AMTB Amerant shares dip 492 after Q1 2026 EPS narrowly misses analyst consensus estimates